Company: NUTR
Filing Date: 2025-08-15
Form Type: 424B3
Source: 0001641172-25-024295
Chunk: 0

Company: NUSATRIP Inc
Filing Date: 2025-08-15
Form: 424B3
Chunk 0
---
| PROSPECTUS |     | Filed Pursuant              
 to Rule 424(b)(3)           
 Registration No. 333-285997 |

<div align='center'>NUSATRIP INCORPORATED

1,066,668 Shares of Common Stock</div>

This prospectus relates to the resale of up to 1,066,668 shares of common stock, $0.0001 par value per share (the “Common Stock”), of NusaTrip Incorporated that may be sold from time to time by the Selling Stockholders named in this prospectus, which includes:

| ● | 1,066,668                                                    
 shares of Common Stock held by the Selling Stockholders; and |

We will not receive any proceeds from the sales of Common Stock by the Selling Stockholders.

No sales of the common stock covered by this prospectus shall occur until after the closing of our initial public offering. Our Common Stock has been approved for listing under the symbol “NUTR” on Nasdaq Capital Market.

We are an “emerging growth company”, as defined in the Jumpstart Our Business Startups Act of 2012, under applicable U.S. federal securities laws, and are eligible for reduced public company reporting requirements. See “ Prospectus Summary — Implications of Being an Emerging Growth Company” for more information.

On October 18, 2024, we entered into a securities purchase agreement with the Selling Stockholders. Pursuant to securities purchase agreement, on October 18, 2024, we will issue convertible notes (the “Convertible Notes”) to the Selling Stockholders with an aggregate principal amount of $1,600,002 (the “Convertible Notes Offering”). We are obligated to pay interest to the Selling Stockholders on the outstanding principal amount at the rate of 6.0% per annum. Pursuant to the amendments to the securities purchase agreement for Convertible Notes dated November 13, 2024, entered by the Company and the investors, the Convertible Notes shall automatically convert into shares of our common stock upon the effectiveness of the registration statement at the conversion price of $1.50 per share. The Convertible Notes were converted into an aggregate of 1,066,668 shares of Common Stock and issued to the investors, and the three private placements were completed on February 10, 2025. The Selling Stockholders may offer and sell the Common Stock being offered by this prospectus from time to time in public or private transactions, or both. Thereafter, these sales will